Mengxuan Cao
Overview
Explore the profile of Mengxuan Cao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu C, Xu J, Zhang Y, Zhang R, Pan S, Chen J, et al.
Redox Biol
. 2025 Feb;
80:103519.
PMID: 39908861
Gastric cancer (GC) is one of the most lethal malignancies due to high metastatic rate, making the identification of new therapeutic targets critical for developing effective anti-GC treatments. Glutathione peroxidase...
2.
Cao M, Hu C, Li F, He J, Li E, Zhang R, et al.
Int J Surg
. 2024 Jun;
110(12):7598-7606.
PMID: 38896865
Introduction: The postoperative recurrence of gastric cancer (GC) has a significant impact on the overall prognosis of patients. Therefore, accurately predicting the postoperative recurrence of GC is crucial. Methods: This...
3.
Cao M, Hu C, Pan S, Zhang Y, Yu P, Zhang R, et al.
World J Surg Oncol
. 2024 Jan;
22(1):21.
PMID: 38243254
Background: After radical surgery, early detection of recurrence and metastasis is a crucial factor in enhancing the prognosis and survival of patients with gastric cancer (GC). Therefore, assessing the risk...
4.
Zhang J, Hu C, Zhang R, Xu J, Zhang Y, Yuan L, et al.
Front Immunol
. 2023 Dec;
14:1282176.
PMID: 38143746
As one of the deadliest cancers of the gastrointestinal tract, there has been limited improvement in long-term survival rates for gastric cancer (GC) in recent decades. The poor prognosis is...
5.
Ma Y, Wang Y, Hu C, Zi M, Chen J, Cao M, et al.
Langenbecks Arch Surg
. 2023 Sep;
408(1):376.
PMID: 37743407
Purpose: Only recently has the percentage of signet-ring cells (SRCs) been shown to affect the prognosis following gastric cancer surgery. It is uncertain whether the SRC percentage has a role...
6.
Pan S, Cao M, Hu C, Zhang Y, Du Y, Xu Z, et al.
J Oncol
. 2023 Feb;
2023:8629166.
PMID: 36747903
Background: While early gastric cancer (EGC) patients are likely to experience relatively long postoperative survival, certain disease-related findings are associated with a poorer prognosis. This study sought to develop and...
7.
Zhang R, Hu C, Zhang J, Zhang Y, Yuan L, Yu P, et al.
BMC Cancer
. 2023 Jan;
23(1):5.
PMID: 36597055
Background: It has been reported that inflammatory and nutritional markers are related to prognosis in numerous malignancies. The present study analyzed the significance of these markers' alterations during neoadjuvant chemotherapy...
8.
Yu P, Hu C, Wang Y, Bao Z, Zhang R, Cao M, et al.
BMC Surg
. 2022 Nov;
22(1):401.
PMID: 36404297
Background: Lymph node metastases often occur in advanced gastric cancer, with some patients presenting with metastases in the para-aortic lymph nodes. There are persistent Controversies about the benefit of para-aortic...
9.
Cao J, Hu C, Xu J, Han J, Zhang R, Cao M, et al.
Evid Based Complement Alternat Med
. 2022 Sep;
2022:4257342.
PMID: 36082181
Background: Gastric cancer (GC) is one of the most common malignant tumors with poor prognosis. So far, other than the HER2, GC lacks effective therapeutic targets. Transferrin receptor 1 (TFR1)...
10.
Yu P, He W, Zhang Y, Hu C, Wu Y, Wang Y, et al.
J Oncol
. 2022 Jul;
2022:8829649.
PMID: 35847366
Purpose: Secreted frizzled-related protein 4 (SFRP4) is a member of the SFRP family, which functions as either a tumor suppressor or a prooncogenic factor in distinct tumor types. Our research...